dievini Hopp Biotech Holding

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in Walldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include Novaliq, immatics biotechnologies, Molecular Health, CureVac, and AC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.